Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an…
Biotechnology
US, San Diego [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Capricor Therapeutics, Inc. (CAPR) to it's peer group.
Peer Group
IDYA AKTX UNCY MBRX PULM PHIO NXTC DFFN BPTH CDTX FIXX MGTX KROS ONTX ANAB CBIO SLNO
Compare Together
Loading...